ArticleInternational journal of radiation oncology, biology, physics2026
Improvement of Soft Tissue Contrast and CT Number Accuracy in Proton Therapy CBCT With Hardware-based Scatter Suppression: Results From a Prospective Trial.
Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeAdaptive proton therapy using cone beam CT (CBCT) requires accurate CT numbers for dose calculation and sufficient soft tissue visibility for reliable target and organ delineation. However, scatter in conventional CBCT causes substantial CT number inaccuracies and poor soft tissue contrast, limiting its use in adaptive workflows. To address this, a novel 2-dimensional antiscatter grid (2D ASG) prototype and raw data correction algorithms were developed for a proton gantry-mounted CBCT system. This prospective study evaluated their impact on CBCT image quality in human subjects. METHODS AND MATERIALS: Ten patients undergoing proton therapy for prostate cancer were enrolled in an institutional review board-approved imaging study. Each participant underwent 2 CBCT scans on a gantry-mounted proton therapy CBCT system: (1) standard CBCT with software-based scatter correction and (2) CBCT with the 2D ASG. Acquisition parameters and imaging dose were identical. Quantitative image quality metrics, including CT number error and artifact amplitude relative to planning CT, adipose-soft tissue contrast, contrast-to-noise ratio, peak signal-to-noise ratio, and structural similarity index measure, were calculated. Differences between configurations were assessed using the Wilcoxon signed-rank test.
resultsCompared with scatter-corrected clinical CBCT, the 2D ASG reduced median (min-max) soft tissue CT number errors from 169 (150-185) HU to 38 (26-54) HU (P = .002), indicating reduced scatter-induced artifacts. Median soft tissue contrast increased from 62 (42-74) HU to 125 (97-144) HU (P = .002), and contrast-to-noise ratio improved from 0.99 (0.37-1.38) to 1.57 (1.28-1.75) (P = .002). Structural similarity index measure relative to the planning CT increased from 0.53 (0.38-0.67) to 0.87 (0.85-0.93) (P = .002). Similar improvements were observed for peak signal-to-noise ratio and artifact amplitude.
conclusionsThis first prospective evaluation of a prototype 2D ASG-equipped CBCT system for proton therapy demonstrated significant improvements in CT number accuracy and soft tissue visualization, supporting its potential role in adaptive proton therapy workflows.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.